Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03894631 · ClinicalTrials.gov registry record · NA
Effect of Intra-subject Phaco/Trabectome vs. Phaco/Kahook Dual Blade on Intraocular Pressure
A NA study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03894631 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 80 participants.
The verdict
NCT03894631, a NA study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
To determine the safety and efficacy of Kahook dual blade over Trabectome in lowering intraocular pressure in glaucoma patients. Glaucoma surgery will be performed in conjunction with cataract surgery. The investigators hypothesize that the Kahook dual blade is as effective as Trabectome in lowering intra-ocular pressure (IOP), and as safe with a similar rate of post-operative complications such as hyphema.
Interventions
- PROCEDURE KDB/Phacoemulsification
- PROCEDURE Trabectome/Phacoemulsification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-03-06 |
| Est. Completion | 2023-11-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03894631
The ClinicalTrials.gov registry entry for NCT03894631 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which KDB/Phacoemulsification is the first listed.
NCT03894631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03894631 about?
NCT03894631 is a clinical study titled "Effect of Intra-subject Phaco/Trabectome vs. Phaco/Kahook Dual Blade on Intraocular Pressure". To determine the safety and efficacy of Kahook dual blade over Trabectome in lowering intraocular pressure in glaucoma patients. Glaucoma surgery will be performed in conjunction with cataract surgery. The investigators hypothesize that the Kahook dual blade is as effective as Trabectome in lowering...
What is the current status of trial NCT03894631?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-03-06. Estimated completion is 2023-11-09.
What interventions are being tested in trial NCT03894631?
The interventions under investigation include: KDB/Phacoemulsification (PROCEDURE), Trabectome/Phacoemulsification (PROCEDURE).
Who is sponsoring clinical trial NCT03894631?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.